Filing Details
- Accession Number:
- 0001209191-20-031506
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-21 19:05:26
- Reporting Period:
- 2020-05-19
- Accepted Time:
- 2020-05-21 19:05:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1595893 | Turning Point Therapeutics Inc. | TPTX | Pharmaceutical Preparations (2834) | 463826166 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1772259 | Jean Jingrong Cui | C/O Turning Point Therapeutics, Inc. 10628 Science Center Drive, Ste. 200 San Diego CA 92121 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2020-05-19 | 1,200 | $56.33 | 625,183 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-05-19 | 2,400 | $57.44 | 622,783 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-05-19 | 3,000 | $58.36 | 619,783 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-05-19 | 400 | $58.94 | 619,383 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-05-20 | 500 | $59.04 | 618,883 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-05-20 | 5,100 | $60.03 | 613,783 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-05-20 | 1,400 | $60.98 | 612,383 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-05-21 | 6,900 | $59.64 | 605,483 | No | 4 | S | Indirect | By spouse |
Common Stock | Disposition | 2020-05-21 | 100 | $60.34 | 605,383 | No | 4 | S | Indirect | By spouse |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
No | 4 | S | Indirect | By spouse |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,001,298 | Direct | |
Common Stock | 300,000 | Indirect | By The Jean Cui 2020 GRAT |
Footnotes
- Reported transaction occurred pursuant to Rule 10b5-1 Plan adopted by Yishan (Peter) Li.
- The weighted average sale price for the transaction reported was $56.33, and the range of prices were between $55.785 and $56.750. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $57.44, and the range of prices were between $56.89 and $57.82. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $58.36, and the range of prices were between $57.89 and $58.845. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $58.94, and the range of prices were between $58.905 and $58.975. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $59.04, and the range of prices were between $58.545 and $59.46. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $60.03, and the range of prices were between $59.56 and $60.54. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $60.98, and the range of prices were between $60.60 and $61.25. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- The weighted average sale price for the transaction reported was $59.64, and the range of prices were between $59.13 and $60.07. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.